Medincell SA Market Cap ($790.73 Million)

$790.73 Million USD · €676.36 Million EUR · Rank #9567

Market Cap & Net Worth: Medincell SA (MEDCL)

Medincell SA market cap. Medincell SA (PA:MEDCL) has a market capitalization of $790.73 Million (€676.36 Million) as of November 1, 2026. Listed on the PA stock exchange, this France-based company holds position #9567 globally and #152 in its home market, demonstrating a 0.53% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medincell SA's stock price €26.36 by its total outstanding shares 35909836 (35.91 Million). Also see cash flow conversion of Medincell SA for how efficiently the company converts equity into cash flow.

Medincell SA Market Cap History (2018–2026)

Medincell SA market cap history from 2018 to 2026. Data shows growth from $279.18 Million to $1.11 Billion (17.16% CAGR). Check Medincell SA stock quote for real-time trading data and today's change.

Index Memberships

Medincell SA is a constituent of 6 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
CAC Mid & Small CACMS	$221.72 Billion	0.36%	#55 of 119
CAC Small90 CACS	$35.70 Billion	2.21%	#12 of 64
CAC All-Tradable CACT	$2.79 Trillion	0.03%	#113 of 179
CAC All-Tradable Net Total Return CACTN	$2.79 Trillion	0.03%	#113 of 179
CAC All Tradable Gross Total Return CACTR	$2.79 Trillion	0.03%	#113 of 179
CAC Health Care FRHC	$262.86 Billion	0.30%	#12 of 36

Weight: Medincell SA's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Medincell SA Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Medincell SA's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Medincell SA to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

56.69x

Medincell SA's market cap is 56.69 times its annual revenue

Industry average: 3868.91x Lower than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2018	$279.18 Million	$6.44 Million	-$9.57 Million	43.36x	N/A
2019	$288.84 Million	$1.44 Million	-$19.69 Million	200.17x	N/A
2020	$428.22 Million	$2.85 Million	-$23.91 Million	150.15x	N/A
2021	$419.82 Million	$8.19 Million	-$19.02 Million	51.29x	N/A
2022	$259.45 Million	$4.09 Million	-$24.81 Million	63.44x	N/A
2023	$302.27 Million	$9.94 Million	-$32.01 Million	30.40x	N/A
2024	$697.75 Million	$9.16 Million	-$25.04 Million	76.17x	N/A
2025	$1.06 Billion	$25.54 Million	-$18.44 Million	41.42x	N/A
2026	$1.11 Billion	$19.52 Million	-$31.29 Million	56.69x	N/A

Competitor Companies of MEDCL by Market Capitalization

Companies near Medincell SA in the global market cap rankings as of November 1, 2026. Also see MEDCL asset base for a full breakdown of the balance sheet.

Key companies related to Medincell SA by market ranking:

Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#182	Vertex Pharmaceuticals Inc	NASDAQ:VRTX	$130.90 Billion	$558.88
#371	Regeneron Pharmaceuticals Inc	NASDAQ:REGN	$76.14 Billion	$927.89
#412	CSL Ltd	AU:CSL	$68.91 Billion	AU$200.73
#495	Moderna Inc	NASDAQ:MRNA	$54.14 Billion	$221.72

Market Capitalization of Medincell SA (2018–2026)

Market capitalization of Medincell SA from 2018 to today. Between 2018 and today, Medincell SA's market cap moved from $279.18 Million to $ 1.11 Billion, with a yearly change of 17.16%.

Year	Market Cap	Change (%)
2026	€1.11 Billion	+4.60%
2025	€1.06 Billion	+51.62%
2024	€697.75 Million	+130.83%
2023	€302.27 Million	+16.50%
2022	€259.45 Million	-38.20%
2021	€419.82 Million	-1.96%
2020	€428.22 Million	+48.26%
2019	€288.84 Million	+3.46%
2018	€279.18 Million	--

End of Day Market Cap According to Different Sources

On Oct 31st, 2026 the market cap of Medincell SA was reported to be:

Source	Market Cap
Yahoo Finance	$790.73 Million USD
MoneyControl	$790.73 Million USD
MarketWatch	$790.73 Million USD
marketcap.company	$790.73 Million USD
Reuters	$790.73 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Medincell SA

PA:MEDCL France Biotechnology

Market Cap

$1.11 Billion

€946.58 Million EUR

Market Cap Rank

#9567 Global

#152 in France

Share Price

€26.36

Change (1 day)

+0.38%

52-Week Range

€20.24 - €37.62

All Time High

€38.46